Generated by AI
Quanterix Corporation is a life sciences tools and diagnostics company that develops ultra-sensitive digital immunoassay platforms for research and clinical applications. Quanterix’s core products and services include the Simoa assay kits, automated analyzers, biomarker detection systems, imaging and analysis platforms, and laboratory services used to measure very low levels of proteins and other biomarkers in blood and related fluids. The company supports work across disease research, diagnostics, and drug development, helping laboratories and healthcare organizations generate precise biomarker data for scientific and clinical use. Quanterix serves customers in North America, Europe, the Middle East, Africa, and the Asia Pacific regions, with offerings used by academic researchers, biopharmaceutical companies, and clinical laboratories. Founded in 2007 and headquartered in Billerica, Massachusetts, Quanterix Corporation plays a specialized role in precision biomarker science and advanced diagnostic testing.
WebsiteBuilding 1
Billerica, MA, 01821
United States
The latest articles about QTRX.
Summary of Aug 10's posts. Generated by AI.
Summary of Sep 27's posts. Generated by AI.
Summary of May 9's posts. Generated by AI.
Summary of Aug 10's posts. Generated by AI.
Investors talking about QTRX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.